Q1 2018 13F Holders as of 31 Mar 2018
-
Type / Class
-
Equity / PHARMACEUTCL ETF
-
Total 13F shares
-
1,982,906
-
Share change
-
+415,132
-
Total reported value
-
$112,643,688
-
Put/Call ratio
-
405%
-
Price per share
-
$56.82
-
Number of holders
-
51
-
Value change
-
+$23,538,488
-
Number of buys
-
19
-
Number of sells
-
16
Institutional Holders of VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) as of Q1 2018
As of 31 Mar 2018,
VANECK ETF TRUST - PHARMACEUTCL ETF (PPH) was held by
51 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
1,982,906 shares.
The largest 10 holders included
GOLDMAN SACHS GROUP INC, MEITAV DASH INVESTMENTS LTD, CITIGROUP INC, BANK OF AMERICA CORP /DE/, CLS Investments, LLC, RAYMOND JAMES & ASSOCIATES, MORGAN STANLEY, SG Americas Securities, LLC, Endurant Capital Management LP, and JANE STREET GROUP, LLC.
This page lists
51
institutional shareholders reporting positions in this security
for the Q1 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.